| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |